Skip to main content
Erschienen in:

Open Access 06.09.2024 | How I do it

How I do it: implantation of Osia® 2 system under local anesthesia

verfasst von: Bálint Posta, László Rovó, Zsófia Bere

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 12/2024

Abstract

Introduction

Reviewing the literature, Osia 2 system implantation is predominantly performed under general anesthesia (GA). Although in the pediatric population GA is inevitable, in adult cases, especially with high anesthesiological risks, local anesthesia (LA) is an obvious solution.

Method

The aim of this article is to provide a detailed demonstration of Osia 2 implantation under LA. In our case series of five adult implant recipients, the surgical procedure was carried out without encountering any difficulties during or after the operation.

Conclusion

Based on our experiences, implantation of the Osia® 2 System under local anesthesia is an easy and safe method for patients.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Osia has gained increasing popularity due to its exceptional performance and relatively straightforward surgery. Currently, all the 12 Osia recipients in Hungary (7 pediatric and 6 adult) were implanted in our clinic, and initial experiences with the surgery were reported by the group [1]. From the beginning, we encountered the need for implantation under local anesthesia (LA); intubation or the use of a laryngeal mask in one of our first adult patient with Treacher-Collins syndrome could prove challenging due to the patient’s severe craniofacial malformation and very limited mouth opening, and the patient declined the option of a tracheotomy (Fig. 1A). Therefore, standardized steps of Osia implantation under LA were developed.

Materials and methods

Participants provided their informed consent by signing a form that was approved by the local institutional review board (Human Investigation Review Board, University of Szeged, Albert Szent-Györgyi Clinical Centre; number: 163/2020-SZTE).
Overall, 5 out of 6 adult patients were unilaterally implanted with Osia 2 system under LA (2 female, 3 male, aged 42 ± 7 years).
All patients received premedication consisting of an intramuscular injection of 1 mg atropine, 5 mg midazolam, and 20 mg nalbuphine hydrochloride, administered in combination 20–30 min prior to surgery. For postoperative pain management, a paracetamol 10 mg/ml 50 ml infusion (PARACETAMOL) or diclophenac-orphenadrine 75 mg/30 mg/250 ml (NEODOLPASSE) was administered.

Surgical technique step by step

To ensure continuous monitoring of the patient, a pulse oximeter and a three-wire lead electrocardiogram were attached to the patient. A supplementary oxygen source was administered through either a nasal cannula or a facial mask (Fig. 1A).
The Osia template was used to accurately determine the precise location for creating the incision and placing of OSI200 and BI300. The optimal placement of the transducer is approximately 1–1.5 cm above the midline of the ear canal, similar to the method described by Deep et al., where the flat surface of the bone allows for improved alignment without the need for additional bone removal and provides less protrusion and consequent tension on the sutures [2]. Additionally, the OSI200 implant was tilted anteriorly by approximately 20–25° around its axis in order to get the optimal position for the sound processor. The local infiltration procedure involved using a solution containing 10 ml of lidocaine (20 mg/ml), 0.2 ml of adrenaline (1 mg/ml), and 10 ml of saline. The solution infiltrated the predetermined region, and directly on the top of the bone, acting as a hydrodissector to facilitate the lifting of the periosteum (Fig. 1C). After 5 min, an approximately 5–6 cm arc-shaped incision was performed 1.5 cm from the lower posterior edge of the transducer (Fig. 1D-E). A direct and precise separation of the soft tissue flap was carried out using a scissors and raspatory instrument to establish a space for the OSI200 (Fig. 1F). As a mandatory step, soft tissue was also raised on the other side of the incision line to aid the manipulation with the Langenbeck retractor and later minimize the tension on the suture line. This incision type, together with the extended elevation of the temporal flap, allowed enough space to work comfortably with the Osscora™ Surgical Set to drill the bone bed (Fig. 2A-B). The BI300 fixed, and the OSI200 implant mounted on it (Fig. 2C-D). In one case, where soft tissue reduction was necessary at the level of the coil, a tunnel was created between the temporal and the temporoparietal fascia, and the coil part was inserted between these layers without the necessity of removing subcutaneous fat, while the implant body remained under the periosteum pocket. The musculo-periosteal layer was sutured with hand-tied 2–0 vicryl sutures due to the requirement for sutures capable of withstanding higher stress in this tightly layered area (Fig. 2E). Subsequently, the profound dermal layer and skin were closed in the customary manner. A mastoid dressing was placed on implant area.

Results

The average surgical time was 27 ± 5 min (maximum 35 min). No massive intraoperative bleeding, dura injury, mastoid air cell exposure, or sigmoid sinus exposure was detected. No patients reported experiencing significant pain or discomfort during or after the surgery. There were no further issues related to wound healing or noticeable protrusions at the level of the transducer following the surgeries.

Discussion

Implanting the Osia 2 system under LA can serve as a viable option for patients who face a significant risk of complications from general anesthesia, such as those with a challenging airway or a high ASA score. When comparing experiences with cochlear implantation (CI), CI surgeons tend to prefer using LA in cases where patients have comorbidities that make general anesthesia risky. Factors such as the availability of anaesthesiologist and the financial consequences might also play a role in this decision [3]. It is crucial to highlight that Osia 2 system has dimensions that make the size of the incision and the manipulation of soft tissue more similar to CI; however, it requires only minimal bonework—if it is necessary—compared to other bone-conductive solutions, especially in the modified position presented in our case. Although, proper planning, precise incision and extended flap undermining are necessary due to the thickness and size of the transducer. With tunnel technique, even soft tissue thickness problems in the coil region can be easily handle without the necessity of enlarge the approach. The average surgical time in our patient series also demonstrates that the procedure could be efficiently tolerated under LA, since the effect of the lidocaine infiltration last for 60–90 min, and the preoperative analgosedatives provide anxiolytic-hypnotic effect for 3–4 h. These several aspects contribute to the procedure being viable with the use of local anesthetic.

Conclusion

Implantation of the Osia® 2 System under local anesthesia proves to be an easy and safe method for patients, offering a viable alternative to general anesthesia.

Limitation

Implantation under LA is not recommended in children.

Acknowledgements

We would like to extend our sincere gratitude to Dr. Zoltán Tóbiás for his invaluable assistance in the creation of the schematic drawing featured in this publication.

Declarations

Written informed consent was obtained from the patients who participated in this study.

Conflict of interest

The authors have no conflict of interest to declare.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med HNO

Kombi-Abonnement

Mit e.Med HNO erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes HNO, den Premium-Inhalten der HNO-Fachzeitschriften, inklusive einer gedruckten HNO-Zeitschrift Ihrer Wahl.

Literatur
2.
Zurück zum Zitat Deep NL, Johnson BJ, Kay-Rivest E, Carlson ML, Friedmann DR, Driscoll CLW, Roland T, Jr J, Jethanamest D (2022) Modifications to implanting the OSIA® 2 bone conduction hearing Implant: how I do it. Laryngoscope 132(9):1850–1854. https://doi.org/10.1002/lary.30153 Deep NL, Johnson BJ, Kay-Rivest E, Carlson ML, Friedmann DR, Driscoll CLW, Roland T, Jr J, Jethanamest D (2022) Modifications to implanting the OSIA® 2 bone conduction hearing Implant: how I do it. Laryngoscope 132(9):1850–1854. https://​doi.​org/​10.​1002/​lary.​30153
Metadaten
Titel
How I do it: implantation of Osia® 2 system under local anesthesia
verfasst von
Bálint Posta
László Rovó
Zsófia Bere
Publikationsdatum
06.09.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 12/2024
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-024-08921-5

Neu im Fachgebiet HNO

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Kopf-Hals-Tumore: Lebensqualität von Langzeitüberlebenden

Eine aktuelle Studie des Universitätsklinikums Erlangen verdeutlicht, dass Langzeitüberlebende von Kopf-Hals-Tumoren eine geringe Symptomlast aufweisen. Die am häufigsten auftretenden Beschwerden – Müdigkeit, Angstzustände, Schläfrigkeit und Schmerzen – sollten von den behandelnden Ärztinnen und Ärzten gezielt adressiert werden.

Schlafapnoe – es lag an einer verbogenen Nasenscheidewand

Tritt eine obstruktive Schlafapnoe vor allem in einer bestimmten Seitenlage auf, kann dies auch an einem verbogenen Nasenseptum liegen. Eine Septumplastik lindert die Beschwerden mitunter deutlich.

Das alles ändert sich für Arztpraxen in 2025

  • 31.12.2024
  • EBM
  • Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.